Risk-adapted multimodal laboratory cervical screening - Pap test of the future?;Risikoadaptierte multimodale gynäkozytologische krebsvorsorge. Pap-test der zukunft?

Pathologe

Volumn 28, Issue 5, 2007, Pages 334-338

  Bollmann, R ^a   Varnai, A D ^a   Bankfalvi, A ^b   Bollmann, M ^a  

^a Institut fur Pathologie   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Cervical cancer; Cytology; DNA cytometry; HPV genotyping; Screening

Indexed keywords

BIOLOGICAL MARKER;

DIAGNOSTIC ACCURACY; DISEASE MARKER; HEALTH PROGRAM; HUMAN; LABORATORY TEST; MORTALITY; PAPANICOLAOU TEST; PREVENTION AND CONTROL; REVIEW; RISK FACTOR; SCREENING TEST; UTERINE CERVIX CANCER;

FEMALE; HUMANS; INCIDENCE; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 34548474079     PISSN: 01728113     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00292-007-0923-9     Document Type: Review

References (30)

1. Advisory Committee on Cancer Prevention (2000) Recommendations on cancer screening in the European Union. Eur J Cancer 36: 1473-1478
2. Arbyn M, Buntinx F, Van Ranst M et al. (2004) Virologic versus cytologic trial of women with equivocal Pap smears: a metaanalysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 96: 280-293
3. Becker N (2003) Epidemiological aspects of cancer screening in Germany. J Cancer Res Clin Oncol 129: 691-702
4. Bibbo M, Dytch HE, Alenghat E et al. (1989) DNA ploidy profiles as prognostic indicators in CIN lesions. Am J Clin Pathol 92: 261-265
5. Bollmann M, Bánkfalvi A, Trosic A et al. (2005) Can we detect cervical human papillomavirus (HPV)-infection by cytomorphology alone? Diagnostic value of non-classic cytological signs of HPV effect in minimally abnormal Pap tests. Cytopathology 16: 13-21
6. Bollmann R, Bánkfalvi A, Griefingholt H et al. (2005) Validity of combined cytology and human papillomavirus (HPV) genotyping with adjuvant DNA-cytometry in routine cervical screening: Results from 31031 women from the Bonn-region in West Germany. Oncol Rep 13: 915-922
7. Bollmann R, Mehes G, Speich N et al. (2005) Aberrant highly hyperdiploid cells in HPV-positive abnormal cytological samples are associated with progressive lesions of the uterine cervix. Cancer Cytopathol 105: 96-100
8. Bollmann R, Mehes G, Torka R et al. (2003) Determination of features indicating progression in atypical squamous cells with undetermined significance: Human papillomavirus typing and DNA ploidy analysis from liquid-based cytologic samples. Cancer Cytopathol 99: 113-117
9. Bollmann R, Mehes G, Torka R et al. (2003) Human papillomavirus typing and DNA ploidy determination of squamous intraepithelial lesions in liquid-based cytologic samples. Cancer Cytopathol 99: 57-62
10. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481-488
11. Cuzick J, Szarewski A, Cubie H et al. (2003) Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet 362: 1871-1876
12. Ferreccio C, Bratti MC, Sherman ME et al. (2003) A comparison of single and combined visual, cytologic, and virologic tests as screening strategies in a region at high risk of cervical cancer. Cancer Epidemiol Biomarkers Prev 12: 815-823
13. Grote HJ, Nyuyen HVQ, Leick AG, Böcking A (2004) Identification of progressive cervical epithelial cell abnormalities using DNA image cytometry. Cancer Cytopathol 102: 373-379
14. Gustafsson L, Ponten J, Zack M, Adami HO (1997) International incidence rates of invasive cervical cancer after introduction of cytological screening. Cancer Causes Control 8: 55-63
15. Ho GY, Burk RD, Klein S et al. (1995) Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 87: 1365-1371
16. Kjaer SK, Brule AJ van den, Paul G et al. (2002) Type specific persistence of high risk human papillomavirus (HPV) as indicator of high grade cervical squamous intraepithelial lesions in young women: Population based prospective follow up study. BMJ 325: 1-7
17. Klaes R, Friedrich T, Spitkovsky D et al. (2001) Overexpression of P16INK4a as specific marker for dysplastic and neoplastic epithelial cells of the cervix uteri. Int J Cancer 92: 276-284
18. Kruse AJ, Skaland I, Janssen EA et al. (2004) Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: Role of markers of proliferative activity and differentiation and Rb availability. Int J Gynecol Pathol 23: 100-109
19. Lie AK, Risberg B, Borge B et al. (2005) DNA-versus RNA-based methods for human papillomavirus detection in cervical neoplasia. Gynecol Oncol 97: 908-915
20. Melsheimer P, Vinokurova S, Wentzensen N et al. (2004) DNA aneuploidy and integration of human papillomavirus type 16 e6/e7 oncogenes in intraepithelial neoplasia and invasive squamous cell carcinoma of the cervix uteri. Clin Cancer Res 10: 3059-3063
21. Nanda K, McCrory DC, Myers ER et al. (2000) Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med 132: 810-819
22. Nobbenhuis M, Walboomers JM, Helmerhorst TJ et al. (1999) Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study. Lancet 354: 20-25
23. Parkin DM, Bray FI, Deves SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37: 4-66
24. Petry K-U, Menton S, Loenen-Frosch F van et al. (2003) Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: Results for 8466 patients. Br J Cancer 88: 1570-1577
25. Schiffman M, Solomon D (2003) Findings to date from the ASCUS-LSIL Triage study (ALTS). Arch Pathol Lab Med 127: 946-949
26. Schneider A, Meinhardt G, Villiers EM de, Gissmann L (1987) Sensitivity of the cytologic diagnosis of cervical condyloma in comparison with HPV DNA hybridization studies. Diagn Cytopathol 3: 250-255
27. Schneider A, Hoyer H, Lotz B et al. (2000) Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy. Int J Cancer 89: 529-534
28. Speich N, Schmitt C, Bollmann R, Bollmann M (2004) Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: Genotype spectrum of patients from the west German area. J Med Microbiol 53: 1-4
29. Vizcaino AP, Moreno V, Bosch FX et al. (2000) International trends in the incidence of cervical cancer: II Squamous cell carcinoma. Int J Cancer 86: 429-435
30. Walboomers JMM, Jacobs MV, Manos MM et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189: 1-3